LINPERLISIB

UNII:	05HYK3CV9N
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₈H₃₇FN₆O₅S
Preferred Substance Name:	LINPERLISIB
InChIKey:	NVWKNQGHVMMAJW-UHFFFAOYSA-N
GSRS Full Record:	05HYK3CV9N i

1702816-75-8
Linperlisib [WHO-DD]
METHANESULFONAMIDE, N-(5-(6-FLUORO-8-((4-(1-HYDROXY-1-METHYLETHYL)-1-PIPERIDINYL)METHYL)-2-(4-MORPHOLINYL)-4-QUINAZOLINYL)-2-METHOXY-3-PYRIDINYL)-
N-(5-(6-FLUORO-8-((4-(2-HYDROXYPROPAN-2-YL) PIPERIDIN-1-YL)METHYL)-2-MORPHOLINOQUINAZOLIN-4-YL)-2-METHOXYPYRIDIN-3-)METHANESULFONAMIDE
N-[5-[6-fluoro-8-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-2-morpholin-4-ylquinazolin-4-yl]-2-methoxy-3-pyridinyl]methanesulfonamide
N-[5-[6-fluoro-8-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-2-morpholin-4-ylquinazolin-4-yl]-2-methoxy-3-pyridinyl]methanesulfonamide
PI3K.DELTA.-IN-2
linperlisib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LINPERLISIB

Synonyms and Mappings

Resources